Item Type | Name |
Concept
|
Aged, 80 and over
|
Concept
|
Alkylation
|
Concept
|
Audiometry, Pure-Tone
|
Concept
|
Adolescent
|
Concept
|
Adenine Nucleotides
|
Concept
|
Adjuvants, Pharmaceutic
|
Concept
|
Aged
|
Concept
|
Biotransformation
|
Concept
|
Amino Acid Sequence
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Administration, Oral
|
Concept
|
Adult
|
Concept
|
Aryl Hydrocarbon Hydroxylases
|
Concept
|
B-Lymphocytes
|
Concept
|
Base Sequence
|
Concept
|
Benzimidazoles
|
Concept
|
Biological Availability
|
Concept
|
Carmustine
|
Concept
|
Bayes Theorem
|
Concept
|
DNA Damage
|
Concept
|
DNA Polymerase II
|
Concept
|
Azacitidine
|
Concept
|
Astrocytoma
|
Concept
|
Bilirubin
|
Concept
|
Bleomycin
|
Concept
|
Body Weight
|
Concept
|
Cattle
|
Concept
|
Child
|
Concept
|
Cell Transformation, Viral
|
Concept
|
Cerebellar Neoplasms
|
Concept
|
Floxuridine
|
Concept
|
Cell Transformation, Neoplastic
|
Concept
|
Cisplatin
|
Concept
|
Leucovorin
|
Concept
|
Glutathione Peroxidase
|
Concept
|
Cricetulus
|
Concept
|
Hydroxylation
|
Concept
|
DNA-Binding Proteins
|
Concept
|
Deoxycytidine Kinase
|
Concept
|
Drug Synergism
|
Concept
|
Diet
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
DNA Polymerase I
|
Concept
|
DNA Repair
|
Concept
|
Child, Preschool
|
Concept
|
DNA Mutational Analysis
|
Concept
|
DNA, Neoplasm
|
Concept
|
Cyclophosphamide
|
Concept
|
Daunorubicin
|
Concept
|
Ferredoxin-NADP Reductase
|
Concept
|
Etoposide
|
Concept
|
Cytarabine
|
Concept
|
Dimethylnitrosamine
|
Concept
|
Disease Susceptibility
|
Concept
|
DNA
|
Concept
|
DNA Topoisomerases, Type II
|
Concept
|
Drug Interactions
|
Concept
|
Drug Resistance
|
Concept
|
Inactivation, Metabolic
|
Concept
|
Indoles
|
Concept
|
Infant, Newborn
|
Concept
|
Methyltransferases
|
Concept
|
Microtubule-Associated Proteins
|
Concept
|
Fluorouracil
|
Concept
|
Deoxyadenosines
|
Concept
|
Deoxyguanosine
|
Concept
|
NAD+ Nucleosidase
|
Concept
|
Glioma
|
Concept
|
Glioblastoma
|
Concept
|
Obesity
|
Concept
|
Oncogenes
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Drug Labeling
|
Concept
|
Liver Neoplasms
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Herpesvirus 4, Human
|
Concept
|
Escherichia coli
|
Concept
|
Flow Cytometry
|
Concept
|
Infant
|
Concept
|
Isoelectric Focusing
|
Concept
|
Genetics, Medical
|
Concept
|
Genetics, Population
|
Concept
|
Glutathione
|
Concept
|
Leukocytes, Mononuclear
|
Concept
|
Methylnitrosourea
|
Concept
|
Carcinoma, Hepatocellular
|
Concept
|
Mice, Inbred Strains
|
Concept
|
Mitoguazone
|
Concept
|
Pharmacogenetics
|
Concept
|
Phosphoramide Mustards
|
Concept
|
Pilot Projects
|
Concept
|
Macaca mulatta
|
Concept
|
Mammals
|
Concept
|
Naphthoquinones
|
Concept
|
Methylnitronitrosoguanidine
|
Concept
|
Mice, Transgenic
|
Concept
|
Neoplasm Transplantation
|
Concept
|
Immunohistochemistry
|
Concept
|
Organ Size
|
Concept
|
Organoplatinum Compounds
|
Concept
|
Molecular Sequence Data
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Mice, Nude
|
Concept
|
Middle Aged
|
Concept
|
Random Allocation
|
Concept
|
Mycosis Fungoides
|
Concept
|
Cricetinae
|
Concept
|
Hot Temperature
|
Concept
|
Rhabdomyosarcoma
|
Concept
|
RNA Precursors
|
Concept
|
Interleukin-3
|
Concept
|
Nitrosourea Compounds
|
Concept
|
Neurons
|
Concept
|
Leukemia L1210
|
Concept
|
Ovarian Neoplasms
|
Concept
|
Ovary
|
Concept
|
Oxidation-Reduction
|
Concept
|
Oxidoreductases
|
Concept
|
Liver
|
Concept
|
Lomustine
|
Concept
|
Luciferases
|
Concept
|
Ornithine Decarboxylase
|
Concept
|
Peripheral Nervous System Diseases
|
Concept
|
Medulloblastoma
|
Concept
|
Melphalan
|
Concept
|
Sex Characteristics
|
Concept
|
Sezary Syndrome
|
Concept
|
Mesylates
|
Concept
|
Speech Reception Threshold Test
|
Concept
|
Nitrosamines
|
Concept
|
Poly T
|
Concept
|
Phenobarbital
|
Concept
|
Population Surveillance
|
Concept
|
Preoperative Care
|
Concept
|
Prostatic Neoplasms
|
Concept
|
Protein-Tyrosine Kinases
|
Concept
|
Protein-Arginine N-Methyltransferases
|
Concept
|
Forecasting
|
Concept
|
Genetic Markers
|
Concept
|
Glutamates
|
Concept
|
Idoxuridine
|
Concept
|
Rats, Inbred F344
|
Concept
|
Regression Analysis
|
Concept
|
Guanine
|
Concept
|
Risk Factors
|
Concept
|
Protein Kinases
|
Concept
|
Purines
|
Concept
|
Rats, Nude
|
Concept
|
Salmonella typhimurium
|
Concept
|
Risk
|
Concept
|
Semustine
|
Concept
|
Swine
|
Concept
|
Tachycardia, Supraventricular
|
Concept
|
Thymidine
|
Concept
|
Histones
|
Concept
|
Humans
|
Concept
|
Body Mass Index
|
Concept
|
Linear Models
|
Concept
|
Tretinoin
|
Concept
|
Software
|
Concept
|
Tetrahydrofolates
|
Concept
|
Thermodynamics
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Ketoconazole
|
Concept
|
Universities
|
Concept
|
Rhabdomyosarcoma, Alveolar
|
Concept
|
Oncogene Proteins, Fusion
|
Concept
|
Risk Assessment
|
Concept
|
DNA Adducts
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Caspases
|
Concept
|
Vinca Alkaloids
|
Concept
|
Carboplatin
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
NF-kappa B
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
Myosin Type II
|
Concept
|
DNA Modification Methylases
|
Concept
|
Metabolic Clearance Rate
|
Concept
|
Neoplasms, Second Primary
|
Concept
|
Activin Receptors, Type I
|
Concept
|
Antimutagenic Agents
|
Concept
|
Lymph Nodes
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
Rats, Sprague-Dawley
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
Melanoma
|
Concept
|
Methionine
|
Concept
|
Methylation
|
Concept
|
Treatment Outcome
|
Concept
|
Neoplasm Metastasis
|
Concept
|
Neoplasm Recurrence, Local
|
Concept
|
Neoplasms, Experimental
|
Concept
|
Dihydrouracil Dehydrogenase (NADP)
|
Concept
|
Oligodeoxyribonucleotides
|
Concept
|
Neurites
|
Concept
|
RNA-Binding Proteins
|
Concept
|
Interferon-alpha
|
Concept
|
Gliosarcoma
|
Concept
|
Mice, Knockout
|
Concept
|
DNA, Complementary
|
Concept
|
Disease Progression
|
Concept
|
Apoptosis Regulatory Proteins
|
Concept
|
Hepatocyte Nuclear Factor 1-alpha
|
Concept
|
Simvastatin
|
Concept
|
Caspase 3
|
Concept
|
Base Pair Mismatch
|
Concept
|
Neurofibromin 1
|
Concept
|
Oxazines
|
Concept
|
Myosin Heavy Chains
|
Concept
|
Fluorescent Antibody Technique, Indirect
|
Concept
|
Cladribine
|
Concept
|
Protein Structure, Secondary
|
Concept
|
Oxygenases
|
Concept
|
Gene-Environment Interaction
|
Concept
|
Population Groups
|
Concept
|
DNA Repair Enzymes
|
Concept
|
Systems Biology
|
Concept
|
Geographic Information Systems
|
Concept
|
Proteomics
|
Concept
|
Methylenetetrahydrofolate Reductase (NADPH2)
|
Concept
|
Cortactin
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
Concept
|
Area Under Curve
|
Concept
|
Proto-Oncogene Proteins B-raf
|
Concept
|
Caspase 1
|
Concept
|
Anthracyclines
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
Concept
|
Stem Cell Factor
|
Concept
|
Caspase 12
|
Concept
|
Evidence-Based Medicine
|
Concept
|
bcl-X Protein
|
Concept
|
Peroxidases
|
Concept
|
Phenanthridines
|
Concept
|
Plasma
|
Concept
|
Platinum
|
Concept
|
Polydeoxyribonucleotides
|
Concept
|
Polyethylene Glycols
|
Concept
|
Prodrugs
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Mice
|
Concept
|
Protein Kinase C
|
Concept
|
Rats, Inbred Strains
|
Concept
|
RNA, Ribosomal, 16S
|
Concept
|
Saccharomyces cerevisiae
|
Concept
|
DNA Breaks, Double-Stranded
|
Concept
|
Research Design
|
Concept
|
Protein Phosphatase 1
|
Concept
|
Structure-Activity Relationship
|
Concept
|
DNA Glycosylases
|
Concept
|
Biomedical Research
|
Concept
|
Thrombopoietin
|
Concept
|
Tinnitus
|
Concept
|
Tissue Distribution
|
Concept
|
Rats
|
Concept
|
ADP-ribosyl Cyclase 1
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
Uracil
|
Concept
|
Stereoisomerism
|
Concept
|
Streptozocin
|
Concept
|
Vincristine
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Blotting, Western
|
Concept
|
MutS Homolog 2 Protein
|
Concept
|
DNA Copy Number Variations
|
Concept
|
Open Reading Frames
|
Concept
|
Electronic Health Records
|
Concept
|
Transcription Factor RelA
|
Concept
|
Benzophenanthridines
|
Concept
|
Tubulin
|
Concept
|
Vinblastine
|
Concept
|
Xanthenes
|
Concept
|
Reproducibility of Results
|
Concept
|
Interleukin-11
|
Concept
|
Survival Rate
|
Concept
|
Rhabdomyosarcoma, Embryonal
|
Concept
|
Odds Ratio
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
Concept
|
Patient Selection
|
Concept
|
Receptor, ErbB-2
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
Concept
|
Proliferating Cell Nuclear Antigen
|
Concept
|
Cyclin-Dependent Kinases
|
Concept
|
DNA Methylation
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
Concept
|
Xenograft Model Antitumor Assays
|
Concept
|
Drug Resistance, Multiple
|
Concept
|
Cytochrome P-450 CYP1A2
|
Concept
|
O(6)-Methylguanine-DNA Methyltransferase
|
Concept
|
Inhibitory Concentration 50
|
Concept
|
ADP-ribosyl Cyclase
|
Concept
|
Tumor Suppressor Proteins
|
Concept
|
Organic Anion Transporters
|
Concept
|
DEAD-box RNA Helicases
|
Concept
|
DNA Mismatch Repair
|
Concept
|
Genome-Wide Association Study
|
Concept
|
Precision Medicine
|
Concept
|
RNA, Small Interfering
|
Concept
|
Molecular Sequence Annotation
|
Concept
|
CDC2-CDC28 Kinases
|
Concept
|
Hand-Foot Syndrome
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
Concept
|
GATA3 Transcription Factor
|
Concept
|
Cytochrome P-450 CYP3A
|
Concept
|
Proto-Oncogene Proteins c-bcr
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
Concept
|
Kaplan-Meier Estimate
|
Concept
|
Drug Discovery
|
Concept
|
RNA Isoforms
|
Concept
|
Aldehyde Dehydrogenase
|
Concept
|
Antibodies
|
Concept
|
Brain Neoplasms
|
Concept
|
Chlorambucil
|
Concept
|
Chromatin
|
Concept
|
Colistin
|
Concept
|
Cytosine
|
Concept
|
Deoxycytidine
|
Concept
|
Diethylnitrosamine
|
Concept
|
Dimethylhydrazines
|
Concept
|
DNA, Single-Stranded
|
Concept
|
Doxorubicin
|
Concept
|
Electrochemistry
|
Concept
|
Ethylnitrosourea
|
Concept
|
Folic Acid
|
Concept
|
Ifosfamide
|
Concept
|
Leukemia P388
|
Concept
|
Lymphocytes
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Plicamycin
|
Concept
|
Models, Neurological
|
Concept
|
Monocytes
|
Concept
|
Neuroblastoma
|
Concept
|
Organ Specificity
|
Concept
|
Peptides
|
Concept
|
Phenotype
|
Concept
|
Polyneuropathies
|
Concept
|
Population
|
Concept
|
Predictive Value of Tests
|
Concept
|
Procarbazine
|
Concept
|
Prospective Studies
|
Concept
|
Ribonucleoside Diphosphate Reductase
|
Concept
|
RNA, Ribosomal
|
Concept
|
Speech
|
Concept
|
Thymine
|
Concept
|
Thymus Gland
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
Concept
|
5'-Nucleotidase
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Anticarcinogenic Agents
|
Concept
|
Mitomycin
|
Concept
|
Ribonucleoproteins, Small Nuclear
|
Concept
|
Age of Onset
|
Concept
|
DNA Primers
|
Concept
|
Hyaluronan Receptors
|
Concept
|
Computational Biology
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Maximum Tolerated Dose
|
Concept
|
Genomics
|
Concept
|
Databases, Nucleic Acid
|
Concept
|
MicroRNAs
|
Concept
|
Semaphorins
|
Concept
|
Protein Array Analysis
|
Concept
|
Chromosomes, Human, X
|
Concept
|
Cyclin-Dependent Kinase 2
|
Concept
|
Transcription Factor CHOP
|
Concept
|
Caspase 9
|
Concept
|
Glypicans
|
Concept
|
Young Adult
|
Concept
|
HapMap Project
|
Academic Article
|
5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis.
|
Academic Article
|
Supplemental dietary calcium fails to alter the acute effects of 1,2-dimethylhydrazine on O6-methylguanine, O6-alkylguanine-DNA alkyltransferase and cellular proliferation in the rat colon.
|
Academic Article
|
Pharmacokinetics of O6-benzylguanine in rats and its metabolism by rat liver microsomes.
|
Academic Article
|
Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea.
|
Academic Article
|
Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer.
|
Academic Article
|
Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitus.
|
Academic Article
|
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
|
Academic Article
|
O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.
|
Academic Article
|
Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents.
|
Academic Article
|
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.
|
Academic Article
|
Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2.
|
Academic Article
|
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
|
Academic Article
|
Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats.
|
Academic Article
|
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
|
Academic Article
|
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings.
|
Academic Article
|
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
|
Academic Article
|
Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
|
Academic Article
|
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
|
Academic Article
|
Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.
|
Academic Article
|
Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation.
|
Academic Article
|
O6-benzylguanine and its role in chemotherapy.
|
Academic Article
|
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
|
Academic Article
|
Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity.
|
Academic Article
|
O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
|
Academic Article
|
Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: implications for dacarbazine activation.
|
Academic Article
|
Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice.
|
Academic Article
|
Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
|
Academic Article
|
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors.
|
Academic Article
|
Silence is golden: gene hypermethylation and survival in large-cell lymphoma.
|
Academic Article
|
Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.
|
Academic Article
|
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
|
Academic Article
|
Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
|
Academic Article
|
Effect of O6-benzylguanine on nitrogen mustard-induced toxicity, apoptosis, and mutagenicity in Chinese hamster ovary cells.
|
Academic Article
|
Temozolomide: realizing the promise and potential.
|
Academic Article
|
Debenzylation of O(6)-benzyl-8-oxoguanine in human liver: implications for O(6)-benzylguanine metabolism.
|
Academic Article
|
Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity.
|
Academic Article
|
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.
|
Academic Article
|
Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.
|
Academic Article
|
Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells.
|
Academic Article
|
Molecular mechanisms of resistance and toxicity associated with platinating agents.
|
Academic Article
|
Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
|
Academic Article
|
Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.
|
Academic Article
|
Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy.
|
Academic Article
|
Enhancement of platinum-induced cytotoxicity by O6-benzylguanine.
|
Academic Article
|
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.
|
Academic Article
|
Evaluation of genetic variation contributing to differences in gene expression between populations.
|
Academic Article
|
Genetic variants contributing to daunorubicin-induced cytotoxicity.
|
Academic Article
|
Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure.
|
Academic Article
|
Role of copper transporters in resistance to platinating agents.
|
Academic Article
|
Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans.
|
Academic Article
|
Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines.
|
Academic Article
|
Identification of common genetic variants that account for transcript isoform variation between human populations.
|
Academic Article
|
Identification of genomic regions contributing to etoposide-induced cytotoxicity.
|
Academic Article
|
Role of GADD34 in modulation of cisplatin cytotoxicity.
|
Academic Article
|
Etoposide pathway.
|
Academic Article
|
A pharmacogene database enhanced by the 1000 Genomes Project.
|
Academic Article
|
Gene set enrichment analyses revealed differences in gene expression patterns between males and females.
|
Academic Article
|
SCAN: SNP and copy number annotation.
|
Academic Article
|
Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice.
|
Academic Article
|
Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.
|
Academic Article
|
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.
|
Academic Article
|
The emerging role of microRNAs in drug responses.
|
Academic Article
|
Population differences in microRNA expression and biological implications.
|
Academic Article
|
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.
|
Academic Article
|
Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.
|
Academic Article
|
Exprtarget: an integrative approach to predicting human microRNA targets.
|
Academic Article
|
A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
|
Academic Article
|
Functional consequences of PRPF39 on distant genes and cisplatin sensitivity.
|
Academic Article
|
Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans.
|
Academic Article
|
Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
|
Academic Article
|
Pharmacogenomic discovery using cell-based models.
|
Academic Article
|
An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.
|
Academic Article
|
Relating human genetic variation to variation in drug responses.
|
Academic Article
|
Clinical translation of cell-based pharmacogenomic discovery.
|
Academic Article
|
Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL.
|
Academic Article
|
Copy number polymorphisms and anticancer pharmacogenomics.
|
Academic Article
|
Human liver oxidative metabolism of O6-benzylguanine.
|
Academic Article
|
Sequential therapy with dacarbazine and carmustine: a phase I study.
|
Academic Article
|
Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.
|
Academic Article
|
The HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics.
|
Academic Article
|
Exploring the evolutionary history of the differentially expressed genes between human populations: action of recent positive selection.
|
Academic Article
|
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.
|
Academic Article
|
Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes.
|
Academic Article
|
Comprehensive survey of SNPs in the Affymetrix exon array using the 1000 Genomes dataset.
|
Academic Article
|
The use of genomic information to optimize cancer chemotherapy.
|
Academic Article
|
Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer.
|
Academic Article
|
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
|
Academic Article
|
Pharmacokinetics of oral O6-benzylguanine and evidence of interaction with oral ketoconazole in the rat.
|
Academic Article
|
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
|
Academic Article
|
Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.
|
Academic Article
|
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.
|
Academic Article
|
Mapping genes that contribute to daunorubicin-induced cytotoxicity.
|
Academic Article
|
Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.
|
Academic Article
|
Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
|
Academic Article
|
Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers.
|
Academic Article
|
Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.
|
Academic Article
|
Structural features of substituted purine derivatives compatible with depletion of human O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Use of antibodies to human O6-alkylguanine-DNA alkyltransferase to study the content of this protein in cells treated with O6-benzylguanine or N-methyl-N'-nitro-N-nitrosoguanidine.
|
Academic Article
|
Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.
|
Academic Article
|
Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts.
|
Academic Article
|
Effect of O6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents.
|
Academic Article
|
Sequence specificity of guanine alkylation and repair.
|
Academic Article
|
Intracellular activation of cytotoxic agents: kinetic models for methylnitrosoureas and N-methyl-N'-nitro-N-nitrosoguanidine in cell culture.
|
Academic Article
|
Investigation of the specificity of O6-alkylguanine-DNA-alkyltransferase.
|
Academic Article
|
Use of a dodecadeoxynucleotide to study repair of the O4-methylthymine lesion.
|
Academic Article
|
Extent of formation of O4-methylthymidine in calf thymus DNA methylated by N-methyl-N-nitrosourea and lack of repair of this product by rat liver O6-alkylguanine-DNA-alkyltransferase.
|
Academic Article
|
Specificity of O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Repair of O6-propylguanine and O6-butylguanine in DNA by O6-alkylguanine-DNA alkyltransferases from rat liver and E. coli.
|
Academic Article
|
Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.
|
Academic Article
|
An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
|
Academic Article
|
Comparison of the rates of repair of O6-alkylguanines in DNA by rat liver and bacterial O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Production of antibodies to peptide sequences present in human O6-alkylguanine-DNA alkyltransferase and their use to detect this protein in cell extracts.
|
Academic Article
|
Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.
|
Academic Article
|
Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.
|
Academic Article
|
Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidine.
|
Academic Article
|
Metabolism and disposition of O6-benzyl-2'-deoxyguanosine in Sprague-Dawley rats.
|
Academic Article
|
Repair of O-alkylpyrimidines in mammalian cells: a present consensus.
|
Academic Article
|
Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.
|
Academic Article
|
Activity of temozolomide in the treatment of central nervous system tumor xenografts.
|
Academic Article
|
Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.
|
Academic Article
|
Cell specific differences in O6-methylguanine-DNA methyltransferase activity and removal of O6-methylguanine in rat pulmonary cells.
|
Academic Article
|
Properties and assay of mammalian O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Comparison of repair of methylated pyrimidines in poly(dT) by extracts from rat liver and Escherichia coli.
|
Academic Article
|
Studies of the repair of O6-alkylguanine and O4-alkylthymine in DNA by alkyltransferases from mammalian cells and bacteria.
|
Academic Article
|
Exposure of HeLa cells to 0(6)-alkylguanines increases sensitivity to the cytotoxic effects of alkylating agents.
|
Academic Article
|
Depletion of O6-methylguanine-DNA-methyltransferase in human fibroblasts increases the mutagenic response to N-methyl-N'-nitro-N-nitrosoguanidine.
|
Academic Article
|
The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells.
|
Academic Article
|
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase.
|
Academic Article
|
Anti-neoplastic activity of sequenced administration of O6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo.
|
Academic Article
|
Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.
|
Academic Article
|
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
8-Substituted O6-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine, and related derivatives as inactivators of human O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
|
Academic Article
|
Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 gene.
|
Academic Article
|
O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
|
Academic Article
|
Mechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine.
|
Academic Article
|
The role of O6-alkylguanine-DNA alkyltransferase in protecting Rat4 cells against the mutagenic effects of O6-substituted guanine residues incorporated in codon 12 of the H-ras gene.
|
Academic Article
|
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
|
Academic Article
|
O6-benzylguanine-mediated enhancement of nitrosourea activity in Mer- central nervous system tumor xenografts--implications for clinical trials.
|
Academic Article
|
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
|
Academic Article
|
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
|
Academic Article
|
Somatic acquisition and signaling of TGFBR1*6A in cancer.
|
Academic Article
|
Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
|
Academic Article
|
Modified guanines representing O(6)-alkylation by the cyclophosphamide metabolites acrolein and chloroacetaldehyde: synthesis, stability, and ab initio studies.
|
Academic Article
|
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
|
Academic Article
|
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
O6-methylguanine-DNA methyltransferase activity and promoter methylation status in pediatric rhabdomyosarcoma.
|
Academic Article
|
Allelic loss at the GPx-1 locus in cancer of the head and neck.
|
Academic Article
|
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
|
Academic Article
|
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
|
Academic Article
|
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.
|
Academic Article
|
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.
|
Academic Article
|
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.
|
Academic Article
|
O6-benzylguanine-mediated enhancement of chemotherapy.
|
Academic Article
|
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial.
|
Academic Article
|
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations.
|
Academic Article
|
Genome scan implicates adhesion biological pathways in secondary leukemia.
|
Academic Article
|
Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traits.
|
Academic Article
|
Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.
|
Academic Article
|
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.
|
Academic Article
|
Mouse models of human AML accurately predict chemotherapy response.
|
Academic Article
|
The kinase inhibitor O6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK2.
|
Academic Article
|
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
|
Academic Article
|
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O6-methylguanine-DNA methyltransferase and mismatch repair proteins.
|
Academic Article
|
Lymphoblastoid cell lines in pharmacogenomics: how applicable are they to clinical outcomes?
|
Academic Article
|
Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.
|
Academic Article
|
Use of oligodeoxynucleotides containing O6-alkylguanine for the assay of O6-alkylguanine-DNA-alkyltransferase activity.
|
Academic Article
|
Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
|
Academic Article
|
Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.
|
Academic Article
|
Mechanisms of resistance to the toxicity of cyclophosphamide.
|
Academic Article
|
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
|
Academic Article
|
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.
|
Academic Article
|
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.
|
Academic Article
|
Poly-omic prediction of complex traits: OmicKriging.
|
Academic Article
|
Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels.
|
Academic Article
|
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.
|
Academic Article
|
Genetic and epigenetic variants contributing to clofarabine cytotoxicity.
|
Academic Article
|
Cell cycle arrest in a model of colistin nephrotoxicity.
|
Academic Article
|
Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells.
|
Academic Article
|
SCAN database: facilitating integrative analyses of cytosine modification and expression QTL.
|
Academic Article
|
EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
|
Academic Article
|
The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.
|
Academic Article
|
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.
|
Academic Article
|
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
|
Academic Article
|
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.
|
Academic Article
|
Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
|
Academic Article
|
Characterization of CpG sites that escape methylation on the inactive human X-chromosome.
|
Academic Article
|
Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.
|
Academic Article
|
Chemotherapy-induced peripheral neuropathy: Current status and progress.
|
Academic Article
|
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.
|
Academic Article
|
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
|
Academic Article
|
Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.
|
Academic Article
|
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.
|
Academic Article
|
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
|
Academic Article
|
Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.
|
Academic Article
|
Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group.
|
Academic Article
|
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
|
Academic Article
|
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
|
Academic Article
|
Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.
|
Academic Article
|
Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
|
Academic Article
|
Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancer.
|
Academic Article
|
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
|
Concept
|
Pemetrexed
|
Concept
|
Poly(ADP-ribose) Polymerase Inhibitors
|
Concept
|
Bevacizumab
|
Concept
|
Capecitabine
|
Concept
|
Patient Reported Outcome Measures
|
Concept
|
Poly (ADP-Ribose) Polymerase-1
|
Concept
|
Regulatory Factor X Transcription Factors
|
Concept
|
Copper-transporting ATPases
|
Concept
|
RUNX1 Translocation Partner 1 Protein
|
Concept
|
Patient Outcome Assessment
|
Concept
|
Prostatic Neoplasms, Castration-Resistant
|
Concept
|
Cytochrome P-450 CYP2C19
|
Concept
|
Cytochrome P-450 CYP1B1
|
Concept
|
Cytochrome P-450 CYP2B6
|
Concept
|
Cytochrome P-450 CYP2C9
|
Concept
|
ErbB Receptors
|